Published in
Elsevier, EBioMedicine, (85), p. 104320, 2022
DOI: 10.1016/j.ebiom.2022.104320
Links
Tools
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial
Journal article published in 2022 by
Valentina Guarneri,
Ana Vivancos,
Patricia Villagrasa,
Fara Brasó Maristany,
Maria Vittoria Dieci,
Gaia Griguolo,
Laia Paré,
Mercedes Marín Aguilera,
Federica Miglietta,
Michele Bottosso,
Carlo Alberto Giorgi 
,
Paula Blasco,
Oleguer Castillo,
Patricia Galván,
Joel S. Parker
and other authors.
,
Paula Blasco,
Oleguer Castillo,
Patricia Galván,
Joel S. Parker
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 